FDA Inspection 1311388 — Upstate New York Transplant Services, Inc.
The FDA completed an inspection of Upstate New York Transplant Services, Inc. on Mar 19, 2026 in Tonawanda, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 19, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Tonawanda, NY (United States)